Oscar Tahuahua, Medical Oncology Fellow at the National Cancer Institute of Mexico, shared a post on X about a paper by Mariana Brandão et al. published in Lung Cancer:
“EORTC consensus on resectable stage III NSCLC
105 cases reviewed by 53 experts. Resectability criteria for trials and practice.
A TNM subset was resectable if more than 75% agreed. T1–T4 (size/satellite) w/ N0–N2 single were resectable; N2 multi, bulky/invasive and N3 were unresectable. Only T4 invasion–N0 without consensus.
Most unresectable cases combined more than 2 major anatomic factors.”
Title: Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group
Authors: Mariana Brandão, Elena Prisciandarob, Eleni Xenophontos, Alessio Mariolo, Amir H. Sadeghi, Andrea R. Filippi, Antonin Levy, Artur Bandura, Caroline Caramella, Chris Dickhoff, Constance de Margerie-Mellon, Corinne Faivre-Finn, Daniel Portik, David Sanchez-Lorente, Dirk De Ruysschere, Egbert Smit, Elisa Gobbini, Elie Fadel, Enrico Ruffini, Emanuela Olmetto, Francesco Cortiula, Idris Bahcev, Ilias Houda, Isabelle Opitz, Jarushka Naidoo, John Edwards, Jordi Remon, José Carlos Benitez, Juan Carlos Trujillo, Jules Derks, Karim Amrane, Koen J. Hartemink, Konstantinos Stathopoulos, Lizza E.L. Hendriks, Manoli Iglesias, Mario Occhipinti, Matthias Guckenberger, Niccolo Giaj Levra, Nicolas Girard, Noemi Reguart, Olaf Mercier, Paolo Bironzo, Paul Hofman, René Horsleben Petersen, Riccardo De Angelis, Ronan Abgral, Safae Terrisse, Sanjay Popat, Thomas Pierre, Torsten Gerriet Bluma, Umberto Ricardi, Valeria Dionisia, Thierry Berghmansa, Anne-Marie C. Dingemans
You can read the Full Article in Lung Cancer.
More posts featuring Oscar Tahuahua.
